Pharmaxis Drug Discoveries to be Studied by Respected Scientific Collaborators following Government Grants of $1.4m to Advance Cancer and Skin Disease Treatments
6th Jan 22
Release Date: 06/01/2022 8:25am
- Associate Professor Thomas Cox from the Garvan Institute of Medical Research has been awarded an $827,500 NHMRC Development Grant to lead a multidisciplinary team investigating PXS-5505 as a promising new treatment approach for pancreatic cancer.
- Professor Fiona Wood and Associate Professor Mark Fear of the University of Western Australia have been awarded a $590,200 NHMRC Drug Development Grant to work on a novel small molecule from the Pharmaxis pre-clinical pipeline for tissue repair and inflammatory skin disease.
Categories: News and Media